Sep 23, 2025
Val T. Hoyle- Amount
- $1,001 to $15,000
- Filed
- Oct 10, 2025
Congress ticker disclosure profile
As of July 20 at 8:00 PM EDT
Public STOCK Act rows mentioning
A factual page for public Congressional disclosures that reference MAR. Veridion shows filed rows, disclosed amount ranges, dates, and source links. It does not imply motive or wrongdoing.
90d rows
0
Feed lifetime
43
Member filers
16
Disclosed ranges
$1.2M
Most active member desks
25 buys vs 16 sells
Democrat · House · NJ-5
Democrat · House · FL-22
Public filer · House · NY-22
Democrat · Senate · OR
Republican · House · GA-12
Democrat · House · NV-3
Democrat · House · IL-1
Republican · House · AL-5
Democrat · House · NY-3
Democrat · House · OR-4
Latest trade Mar 27, 2026
Sep 23, 2025
Val T. HoyleMar 14, 2025
Susie LeeAug 2, 2024
Josh GottheimerJul 9, 2024
Josh GottheimerJun 28, 2024
Josh GottheimerJun 7, 2024
Josh GottheimerMar 13, 2024
Josh GottheimerOct 11, 2023
Jonathan L. JacksonSep 8, 2023
Lois FrankelJul 13, 2023
Lois FrankelNov 16, 2022
Josh GottheimerMay 26, 2022
Josh GottheimerMar 9, 2022
Lois FrankelNov 17, 2021
Lois FrankelSep 24, 2021
Lois FrankelAug 21, 2020
Thomas R. SuozziAug 3, 2020
Ron WydenJul 8, 2020
Susie LeeJun 5, 2020
Ron WydenJun 4, 2020
Ron WydenMay 14, 2020
Rick W. AllenApr 29, 2020
Mo BrooksOct 17, 2019
Rick W. AllenJun 7, 2016
Richard L. HannaDec 22, 2015
Richard L. HannaOct 14, 2015
Richard L. HannaJun 18, 2015
Richard L. Hanna| Date | Member | Action | Amount | Filed | Receipt |
|---|---|---|---|---|---|
| Sep 23, 2025 | Val T. Hoyle | Sell | $1,001 to $15,000 | Oct 10, 2025 | Open card |
| Mar 14, 2025 | Susie Lee | Sell | $1,001 to $15,000 | Apr 11, 2025 | Open card |
| Aug 2, 2024 | Josh Gottheimer | Sell | $1,001 to $15,000 | Sep 11, 2024 | Open card |
| Jul 9, 2024 | Josh Gottheimer | Sell | $1,001 to $15,000 | Aug 15, 2024 | Open card |
| Jun 28, 2024 | Josh Gottheimer | Sell | $1,001 to $15,000 | Jul 9, 2024 | Open card |
| Jun 7, 2024 | Josh Gottheimer | Sell | $1,001 to $15,000 | Jul 9, 2024 | Open card |
| Mar 13, 2024 | Josh Gottheimer | Sell | $1,001 to $15,000 | Apr 7, 2024 | Open card |
| Oct 11, 2023 | Jonathan L. Jackson | Buy | $15,001 to $50,000 | Nov 16, 2023 | Open card |
| Sep 8, 2023 | Lois Frankel | Sell | $1,001 to $15,000 | Oct 10, 2023 | Open card |
| Jul 13, 2023 | Lois Frankel | Sell | $1,001 to $15,000 | Jul 28, 2023 | Open card |
| Nov 16, 2022 | Josh Gottheimer | Buy | $1,001 to $15,000 | Dec 17, 2022 | Open card |
| May 26, 2022 | Josh Gottheimer | Buy | $1,001 to $15,000 | Jun 16, 2022 | Open card |
| Mar 9, 2022 | Lois Frankel | Buy | $1,001 to $15,000 | Apr 6, 2022 | Open card |
| Nov 17, 2021 | Lois Frankel | Buy | $1,001 to $15,000 | Dec 30, 2021 | Open card |
| Sep 24, 2021 | Lois Frankel | Buy | $1,001 to $15,000 | Nov 1, 2021 | Open card |
| Aug 21, 2020 | Thomas R. Suozzi | Sell | $1,001 to $15,000 | Sep 23, 2021 | Open card |
| Aug 3, 2020 | Ron Wyden | Sell | $100,001 to $250,000 | Aug 29, 2020 | Open card |
| Jul 8, 2020 | Susie Lee | Sell | $15,001 to $50,000 | Sep 3, 2020 | Open card |
| Jun 5, 2020 | Ron Wyden | Buy | $50,001 to $100,000 | Jul 2, 2020 | Open card |
| Jun 4, 2020 | Ron Wyden | Buy | $15,001 to $50,000 | Jul 2, 2020 | Open card |
| May 14, 2020 | Rick W. Allen | Buy | $15,001 to $50,000 | Aug 10, 2023 | Open card |
| Apr 29, 2020 | Mo Brooks | Sell | $15,001 to $50,000 | May 22, 2020 | Open card |
| Oct 17, 2019 | Rick W. Allen | Sell | $15,001 to $50,000 | Aug 10, 2023 | Open card |
| Jun 7, 2016 | Richard L. Hanna | Buy | $50,001 to $100,000 | Aug 1, 2016 | Open card |
| Dec 22, 2015 | Richard L. Hanna | Sell | $100,001 to $250,000 | Jan 15, 2016 | Open card |
| Oct 14, 2015 | Richard L. Hanna | Buy | $15,001 to $50,000 | Nov 9, 2015 | Open card |
| Jun 18, 2015 | Richard L. Hanna | Buy | $15,001 to $50,000 | Jul 20, 2015 | Open card |
Source creed
This page is assembled from public STOCK Act disclosure records in the Veridion warehouse. 43 of 43 filed rows include disclosed amount ranges (100%). Rows without ranges stay labeled. Identification only; it does not imply motive or wrongdoing.
Disclosure findings, methodology notes, and product updates when we have them. No fixed schedule yet. No advertising list resale.